WESCO INTERNATIONAL INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WESCO INTERNATIONAL INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $2.10B | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $2.15B | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $2.15B | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $1.96B | Feb 24, 2020 |
| FY2019 | Dec 31, 2018 | $2.01B | Feb 24, 2020 |
| FY2019 | Sep 30, 2018 | $2.07B | Feb 24, 2020 |
| FY2019 | Jun 30, 2018 | $2.10B | Feb 24, 2020 |
| FY2019 | Mar 31, 2018 | $1.99B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.00B | Feb 27, 2019 |
| FY2018 | Sep 30, 2017 | $2.00B | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.51B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $21.82B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $22.39B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $21.42B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $18.22B | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $4.13B | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $4.14B | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $2.09B | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $1.97B | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $2.10B | Mar 1, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.00B | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $2.00B | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $1.91B | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $1.77B | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $1.79B | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $1.86B | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $1.91B | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $1.78B | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $1.86B | Feb 22, 2017 |
| FY2016 | Sep 30, 2015 | $1.92B | Feb 22, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $771.95M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $785.54M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $393.78M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $376.40M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $389.79M | Mar 1, 2021 |
| FY2020 | Sep 30, 2019 | $400.20M | Mar 1, 2021 |
| FY2020 | Jun 30, 2019 | $408.97M | Mar 1, 2021 |
| FY2020 | Mar 31, 2019 | $382.50M | Mar 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $640.20M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $717.60M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $765.50M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $860.50M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $465.40M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $100.56M | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $53.10M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $64.50M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $63.46M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $42.37M | Feb 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.22B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.41B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.44B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $801.90M | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | $92.76M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $178.10M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | $15.27M | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $60.91M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $83.81M | Mar 1, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.54B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.31B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $3.26B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $3.04B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $2.79B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.86B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.17B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.15B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.10B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.05B | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $125.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.10B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $493.20M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $11.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $67.10M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $543.93M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $224.37M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $296.72M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $149.12M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $300.24M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.49B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $15.06B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $15.06B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $14.81B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $12.62B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $11.88B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.02B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.61B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $4.74B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.43B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.47B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $10.10B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $10.03B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $10.36B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $8.84B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $8.54B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.76B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.48B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.62B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.47B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.03B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.97B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.04B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $4.45B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $3.78B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $3.34B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $2.27B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $2.14B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.12B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.97B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.34B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.28B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $3.26B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $3.24B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.21B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $3.19B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.76B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.72B | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.77B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $1.73B | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.51B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.96B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $4.39B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $3.80B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $3.00B | Feb 21, 2023 |
| FY2022 | Dec 31, 2020 | $2.60B | Feb 21, 2023 |
| FY2022 | Dec 31, 2019 | $2.53B | Feb 21, 2023 |
| FY2021 | Dec 31, 2018 | $2.31B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $2.08B | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $1.91B | Feb 24, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $212.58M | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | $449.14M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $150.90M | Feb 25, 2022 |
| FY2021 | Dec 31, 2018 | $96.34M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $117.95M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $110.13M | Feb 24, 2020 |
| FY2018 | Dec 31, 2015 | $160.28M | Feb 27, 2019 |
| FY2017 | Dec 31, 2014 | $128.32M | Feb 22, 2018 |
| FY2016 | Dec 31, 2013 | $123.73M | Feb 22, 2017 |
| FY2015 | Dec 31, 2012 | $86.10M | Feb 22, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $1.23B | Feb 27, 2019 |
| FY2017 | Dec 31, 2017 | $1.36B | Feb 22, 2018 |
| FY2016 | Dec 31, 2016 | $1.40B | Feb 22, 2017 |
| FY2015 | Dec 31, 2015 | $1.50B | Feb 22, 2016 |
| FY2014 | Dec 31, 2014 | $1.42B | Feb 24, 2015 |
| FY2013 | Dec 31, 2013 | $1.49B | Feb 21, 2014 |
| FY2012 | Dec 31, 2012 | $1.74B | Mar 1, 2013 |
| FY2011 | Dec 31, 2011 | $649.33M | Feb 22, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 13 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 8 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 13 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 20, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Mar 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | 43.01M | Feb 25, 2011 |
| FY2010 | Dec 31, 2009 | 42.42M | Feb 25, 2011 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.40M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $81.50M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $76.60M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $0 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $0 | Feb 20, 2024 |